Format

Send to

Choose Destination
J Immunother Cancer. 2017 Sep 28;5(1):80. doi: 10.1186/s40425-017-0280-z.

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.

Author information

1
University of Texas MD Anderson Cancer Center, 1515 Pressler Unit 1373, Houston, TX, 77030, USA. akamat@mdanderson.org.
2
Dana-Farber Cancer Institute, Brookline, MA, 02446, USA.
3
Tisch Cancer Institute at Mount Sinai Medical Center, New York, NY, 10029, USA.
4
University of Minnesota, Minneapolis, MN, 55455, USA.
5
BCG Oncology, Phoenix, AZ, 85032, USA.
6
Bladder Cancer Advocacy Network, North Carolina Triangle Chapter, Chapel Hill, NC, 27517, USA.
7
The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
8
University of North Carolina, Chapel Hill, NC, 27599, USA.
9
University of Iowa, Iowa City, IA, 52242, USA.
10
University of Chicago, Chicago, IL, 60637, USA.
11
Yale Cancer Center, New Haven, CT, 06520, USA.
12
University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
13
Stanford University, Stanford, CA, 94305, USA.
14
University of Alabama, Birmingham, AL, 35294, USA.
15
University of Kansas Cancer Center, Kansas City, KS, 66160, USA.
16
Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center